Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics

Author(s): Andras Polyak*, Tobias L. Ross*.

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 34 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Background: PET and SPECT imaging methods can be of excellent assistance for the development of new nanoparticle drug delivery systems, and at the same time, these investigations also offer the opportunity to produce exceptional new diagnostic and therapeutic radiopharmaceuticals, as well.

With a multifunctional, nano-scaled drug delivery system, the diagnostic (imaging) methods and the therapy (delivering drugs or beta-emitter radionuclides) can be carried out using the same biological and pharmacological mechanisms. By combining therapy and diagnostics in one method or in one specifically targeted nanoparticle system, we can product theranostic pharmaceuticals, and its applications are important elements of personalized medicine.

Objectives: This review takes a short historical look back to the radiocolloids, the great ancestors of (radiolabeled) nanoparticles and then describes the general features of current types of PET and SPECT imaging associated nanoparticle-based products and key radiolabeling methods; entering into details of potential prospective challenges related to radiotheranostic approaches and imaging guided therapy.

Keywords: PET, SPECT, nanomedicine, nanoparticles, theranostics, personalized medicine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [4328 - 4353]
Pages: 26
DOI: 10.2174/0929867324666170830095553
Price: $58

Article Metrics

PDF: 29
PRC: 1